2023
Sex-Discordant Fecal Microbiota Transplantation for C. difficile may increase risk of post-infection irritable bowel syndrome.
Sehgal K, Yadav D, Saha S, Mara K, Grover M, Khanna S. Sex-Discordant Fecal Microbiota Transplantation for C. difficile may increase risk of post-infection irritable bowel syndrome. Gastroenterology 2023 PMID: 38056511, DOI: 10.1053/j.gastro.2023.11.295.Peer-Reviewed Original Research In PressBile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing.
Tome J, Sehgal K, Kamboj AK, Harmsen WS, Khanna S, Pardi DS. Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing. Clin Gastroenterol Hepatol 2023, 21: 3125-3131.e2. PMID: 37172800, DOI: 10.1016/j.cgh.2023.04.031.Peer-Reviewed Original ResearchThe real efficacy of microbiota restoration following standard of care antimicrobial in patients with recurrent Clostridiodes difficile
Sehgal K, Feuerstadt P. The real efficacy of microbiota restoration following standard of care antimicrobial in patients with recurrent Clostridiodes difficile. Translational Gastroenterology And Hepatology 2023, 8: 31-31. PMID: 38021361, PMCID: PMC10643224, DOI: 10.21037/tgh-23-46.Peer-Reviewed Original ResearchThe natural history of histological changes in microscopic colitis.
Sehgal K, Tome J, Kamboj AK, Dierkhising RA, Pardi DS, Khanna S. The natural history of histological changes in microscopic colitis. Therap Adv Gastroenterol 2023, 16: 17562848231168237. PMID: 37124370, DOI: 10.1177/17562848231168237.Peer-Reviewed Original Research
2022
Treatment of Clostridioides difficile Infection.
Sehgal K, Cifu AS, Khanna S. Treatment of Clostridioides difficile Infection. JAMA 2022, 328: 881-882. PMID: 35939317, DOI: 10.1001/jama.2022.12251.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThe Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019.
Tome J, Sehgal K, Kamboj AK, Harmsen WS, Kammer PP, Loftus EV, Tremaine WJ, Khanna S, Pardi DS. The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019. Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association 2022, 20: 1085-1094. PMID: 34216819, PMCID: PMC8716639, DOI: 10.1016/j.cgh.2021.06.027.Peer-Reviewed Original ResearchBudesonide Maintenance in Microscopic Colitis: Clinical Outcomes and Safety Profile from a Population-Based Study.
Tome J, Sehgal K, Kamboj AK, Comstock B, Harmsen WS, Khanna S, Pardi DS. Budesonide Maintenance in Microscopic Colitis: Clinical Outcomes and Safety Profile from a Population-Based Study. The American Journal Of Gastroenterology 2022 PMID: 35417427, DOI: 10.14309/ajg.0000000000001774.Peer-Reviewed Original ResearchSystematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection.
Sehgal K, Zandvakili I, Tariq R, Pardi DS, Khanna S. Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection. Expert Review Of Anti-infective Therapy 2022, 20: 577-583. PMID: 34693838, DOI: 10.1080/14787210.2022.1997588.Peer-Reviewed Original ResearchPostinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis.
Saha S, Sehgal K, Singh S, Grover M, Pardi D, Khanna S. Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis. Journal Of Clinical Gastroenterology 2022, 56: e84-e93. PMID: 34049374, PMCID: PMC8627535, DOI: 10.1097/MCG.0000000000001536.Peer-Reviewed Original Research
2021
Gut microbiome and checkpoint inhibitor colitis.
Sehgal K, Khanna S. Gut microbiome and checkpoint inhibitor colitis. Intestinal Research 2021, 19: 360-364. PMID: 33249800, PMCID: PMC8566823, DOI: 10.5217/ir.2020.00116.Peer-Reviewed Original ResearchGut microbiota: a target for intervention in obesity.
Sehgal K, Khanna S. Gut microbiota: a target for intervention in obesity. Expert Review Of Gastroenterology & Hepatology 2021, 15: 1169-1179. PMID: 34329563, DOI: 10.1080/17474124.2021.1963232.Peer-Reviewed Original ResearchGut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface.
Sehgal K, Khanna S. Gut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface. Therapeutic Advances In Gastroenterology 2021, 14: 1756284821994736. PMID: 33747125, PMCID: PMC7905718, DOI: 10.1177/1756284821994736.Peer-Reviewed Original ResearchOutcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection.
Sehgal K, Fadel HJ, Tande AJ, Pardi DS, Khanna S. Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection. Infection And Drug Resistance 2021, 14: 1645-1648. PMID: 33953575, PMCID: PMC8089469, DOI: 10.2147/IDR.S305349.Peer-Reviewed Original ResearchImmune response against Clostridioides difficile and translation to therapy.
Sehgal K, Khanna S. Immune response against Clostridioides difficile and translation to therapy. Therapeutic Advances In Gastroenterology 2021, 14: 17562848211014817. PMID: 33995585, PMCID: PMC8111532, DOI: 10.1177/17562848211014817.Peer-Reviewed Original ResearchThe interplay of Clostridioides difficile infection and inflammatory bowel disease.
Sehgal K, Yadav D, Khanna S. The interplay of Clostridioides difficile infection and inflammatory bowel disease. Therapeutic Advances In Gastroenterology 2021, 14: 17562848211020285. PMID: 34104215, PMCID: PMC8170344, DOI: 10.1177/17562848211020285.Peer-Reviewed Original Research